Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 101137237 | Other Grant/Funding Number | EU Horizon 2030 grant |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| MINDCONSOLE GMBH | UNKNOWN |
| Medizinische Privatuniversität Burgenland | UNKNOWN |
| Central Institute of Mental Health, Mannheim | OTHER |
| St. Pölten University of Applied Sciences |
Not provided
Not provided
Not provided
Not provided
This study investigates the effectiveness of an extended reality (XR) based resilience training program designed to support the mental health and well-being of nurses working in hospital settings. Nurses are exposed to high emotional, cognitive, and organizational demands and show elevated levels of work-related stress and stress-associated mental health problems. Strengthening resilience and coping capacities is therefore an important preventive approach to support nurses' well-being and sustain quality of care.
The study is conducted as a pragmatic randomized controlled trial with a waitlist control group and includes approximately 232 nurses from hospitals in several European countries. Participants are randomly assigned either to an XR-based resilience training group or to a waitlist control group that continues with care as usual during the waiting period. The XR-based intervention consists of eight immersive training sessions delivered over approximately ten weeks using a head-mounted display. The training focuses on behavioral, cognitive, and emotional coping strategies and aims to enhance key resilience factors such as problem-solving, cognitive reappraisal, emotion regulation, and positive self-care.
The primary outcome is perceived stress, assessed using the Perceived Stress Scale. Secondary outcomes include resilience, occupational self-efficacy, quality of life, psychological distress, burnout symptoms, coping strategies, work-related rumination, and turnover intentions. Assessments are conducted at baseline, post-intervention, and at a 20-week follow-up. In addition, a subgroup of participants will optionally provide physiological data during selected XR sessions to explore digital biomarkers related to stress and recovery.
The findings of this study will provide evidence on the effectiveness, feasibility, and acceptance of XR-based resilience training for nurses and inform future implementation of digital mental health interventions in healthcare workplaces.
This study is part of the XR2ESILIENCE project, a European multicenter research initiative aimed at promoting resilience and mental health among healthcare professionals through innovative extended reality (XR) technologies. The present randomized controlled trial evaluates the effectiveness of a newly developed XR-based resilience training program for nurses working in hospital settings.
Nurses are frequently exposed to high workload, emotional labor, time pressure, and organizational stressors, which are associated with increased stress levels, burnout symptoms, and mental health impairments. Despite the high relevance of resilience promotion in this occupational group, accessible and scalable preventive interventions remain limited. XR technology offers the opportunity to deliver immersive, engaging, and standardized resilience training that can be flexibly integrated into clinical and non-clinical settings.
The study uses a pragmatic, parallel-group, waitlist-controlled randomized design. A total of approximately 232 nurses aged 18 to 65 years will be recruited across multiple hospital sites in Europe. After completion of baseline assessments and provision of informed consent, participants are randomly allocated in a 1:1 ratio either to the XR-based intervention group or to a waitlist control group. The control group continues with care as usual and receives access to the intervention after the waiting period.
The XR-based resilience training consists of eight sessions delivered over approximately ten weeks using a standalone head-mounted display. Each session lasts around 20 to 30 minutes. The training is structured into modules addressing behavioral coping (e.g., problem-solving and proactive coping), cognitive coping (e.g., appraisal and reappraisal of stressors), and emotional coping (e.g., emotion regulation, acceptance, and fostering positive emotions). The intervention is theoretically grounded in contemporary resilience frameworks and the concept of regulatory flexibility. Participants complete the sessions individually, with technical support available if needed.
The primary outcome is perceived stress measured by the 10-item Perceived Stress Scale at post-intervention. Secondary outcomes include resilience, occupational self-efficacy, psychological distress, burnout symptoms, coping strategies, work-related rumination, quality of life, and career-related variables such as turnover intentions. Data are collected at baseline, immediately after the intervention period, and at a 20-week follow-up.
In addition to questionnaire-based outcomes, optional digital biomarker data are collected during selected XR sessions to explore physiological indicators of stress and recovery, such as heart rate variability and other sensor-based measures, depending on study site capabilities. User experience, technology acceptance, satisfaction, and potential side effects of XR use are assessed descriptively after completion of the intervention.
The study follows an intention-to-treat approach for primary analyses. Results are expected to provide robust evidence on whether XR-based resilience training can reduce perceived stress and improve mental health outcomes among nurses. The findings will also inform the feasibility, acceptability, and potential health-economic value of implementing XR-supported resilience interventions in hospital workplaces.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| XR-based Resilience Training | Experimental | Participants in this arm receive an XR-based resilience training consisting of eight immersive sessions delivered over approximately ten weeks using a head-mounted display. The training focuses on behavioral, cognitive, and emotional coping strategies and aims to strengthen resilience and stress management skills. Each session lasts approximately 20 to 30 minutes and is completed individually. |
|
| Waitlist Control | No Intervention | Participants in this arm are assigned to a waitlist control condition and continue with care as usual during the waiting period. They do not receive the XR-based resilience training during the first ten weeks of the study but are offered access to the intervention after completion of the post-intervention assessment. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| XR-based Resilience Training | Behavioral | The XR-based resilience training is delivered via a standalone extended reality head-mounted display and consists of eight immersive sessions over approximately ten weeks. The training addresses behavioral coping strategies such as problem solving, cognitive coping strategies such as appraisal and reappraisal of stressors, and emotional coping strategies including emotion regulation and positive self-care. Sessions last approximately 20 to 30 minutes and are completed individually with technical support available if needed. |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived Stress Assessed by PSS-10 | Perceived stress measured using the 10-item Perceived Stress Scale (PSS-10). The PSS-10 assesses the degree to which situations in one's life are appraised as stressful during the past month. Scores range from 0 to 40, with higher scores indicating higher perceived stress. | Baseline, 10 weeks post-randomization & 20 weeks post-randomization |
| Measure | Description | Time Frame |
|---|---|---|
| Resilience Assessed by BRS | Self-perceived resilience will be assessed using the Brief Resilience Scale (BRS), a self-report measure consisting of six items rated on a 5-point Likert scale. Total scores are calculated by summing item responses (range: 6 to 30) and dividing by the number of items answered, resulting in a mean score ranging from 1 to 5. Higher scores indicate greater resilience. | Baseline, 10 weeks post-randomization & 20 weeks post-randomization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nina Dalkner Research Prof. Priv.-Doz. Mag. rer.nat. Dr. rer.nat. | Contact | +43 316 385 30081 | nina.dalkner@medunigraz.at |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Graz, Clinical Division of Psychiatry and Psychotherapeutic Medicine | Graz | Styria | 8036 | Austria |
Not provided
| Label | URL |
|---|---|
| Website for the overall EU-project | View source |
Not provided
De-identified individual participant data that underlie the results reported in publications will be made available upon reasonable request. Data will be shared in a pseudonymized form to qualified researchers for purposes of academic research and secondary analyses that are consistent with the original study objectives. Requests will be reviewed by the study steering committee and require a methodologically sound proposal and a data use agreement. Data sharing will be subject to applicable data protection regulations and ethical approvals.
Not provided
Beginning 6 months after publication of the primary results and ending 5 years thereafter
Researchers must submit a written request including a study proposal statistical analysis plan and intended use of the data. Approval by the study steering committee and a signed data use agreement are required prior to data access.
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP_ICF | Yes | Yes | Yes | Study Protocol, Statistical Analysis Plan, and Informed Consent Form | Mar 26, 2026 |
Not provided
| OTHER |
| University of Évora | OTHER |
| Leibniz Institute for Resilience Research (LIR), Mainz, Germany | UNKNOWN |
| Leuphana Universität Lünenberg | UNKNOWN |
| University of Lisbon | OTHER |
| Sveti Ivan Psychiatric Hospital | OTHER |
| mindconsole | UNKNOWN |
| PredictBy Research and Consulting, S.L | INDUSTRY |
| Servicio Madrileño de Salud (SERMAS) | UNKNOWN |
waitlist-controlled trial
Not provided
Not provided
This is an open-label trial. Due to the nature of the XR-based intervention and the waitlist control design, blinding of participants and study personnel is not feasible.
Not provided
|
| Waitlist Control | Other | Participants assigned to the waitlist control condition receive no active intervention during the initial study period and continue with care as usual. After completion of the post-intervention assessment, participants are offered access to the XR-based resilience training. |
|
| Occupational Self-Efficacy Assessed by OSE-SF | Occupational self-efficacy will be assessed using the Occupational Self-Efficacy Scale - Short Form (OSE-SF), a self-report measure consisting of items rated on a 6-point Likert scale ranging from 1 (not at all true) to 6 (completely true). Total scores are calculated by summing item responses, with higher scores indicating greater occupational self-efficacy. | Baseline and 10 weeks post-randomization |
| Psychological Distress Assessed by GHQ-12 | Psychological distress will be assessed using the General Health Questionnaire-12 (GHQ-12), a 12-item self-report measure with items rated on a 4-point Likert scale (0 to 3). Total scores range from 0 to 36, with higher scores indicating greater psychological distress. | Baseline and 10 weeks post-randomization |
| Burnout symptoms Assessed by BAT-12 | Burnout symptoms will be assessed using the Burnout Assessment Tool - Short Version (BAT-12), a 12-item self-report measure with items rated on a 5-point Likert scale ranging from 1 (never) to 5 (always). Total scores range from 12 to 60, with higher scores indicating higher levels of burnout-related symptoms. | Baseline and 10 weeks post-randomization |
| Coping Strategies Assessed by CSI-SF | Coping strategies will be assessed using the Coping Strategies Inventory - Short Form (CSI-SF). The CSI-SF is a 16-item measure rated on a 5-point Likert scale ranging from 1 to 5. Subscale scores range from 4 to 20, with higher scores indicating greater use of coping strategies. | Baseline, 10 weeks post-randomization & 20 weeks post-randomization |
| Coping Flexibility Assessed by CFS-R | Coping flexibility will be assessed using the Coping Flexibility Scale - Revised (CFS-R). The CFS-R is a 10-item measure rated on a 4-point Likert scale ranging from 0 to 3. Total scores range from 0 to 30, with higher scores indicating greater coping flexibility. | Baseline, 10 weeks post-randomization & 20 weeks post-randomization |
| Health-Related Quality of Life Assessed by EQ-5D-5L | Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), a standardized instrument comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on a 5-level scale (1 to 5). Health states are converted into a single index value using a country-specific value set, typically ranging from less than 0 (worse than death) to 1 (full health), with higher values indicating better perceived health status. | Baseline and 10 weeks post-randomization |
| Turnover intentions | Turnover intentions assessed using self-developed items measuring intention to leave the profession or current workplace. | Baseline and 10 weeks post-randomization |
| User Experience Assessed With the AttrakDiff Mini | User experience will be assessed using the AttrakDiff Mini. The AttrakDiff Mini is a 10-item measure rated on a 7-point bipolar scale ranging from -3 to +3. Higher scores indicate a more positive user experience. | 10 weeks post-randomization (Training Group) or 20 weeks post-randomization (Control Group) |
| User Satisfaction Assessed With the Client Satisfaction Questionnaire for Internet-Based Interventions | User satisfaction will be assessed using the Client Satisfaction Questionnaire adapted for Internet-based interventions (CSQ-I). The CSQ-I is an 8-item measure rated on a 4-point Likert scale. Total scores range from 8 to 32, with higher scores indicating greater satisfaction. | 10 weeks post-randomization (Training Group) or 20 weeks post-randomization (Control Group) |
| VR-Related Side Effects Assessed With the Virtual Reality Neuroscience Questionnaire | VR-related side effects will be assessed using the Virtual Reality Neuroscience Questionnaire (VRNQ), specifically the Virtual Reality-Induced Symptoms and Effects (VRISE) subscale. Items are rated on a 7-point Likert scale, with higher scores indicating lower intensity of side effects. | 10 weeks post-randomization (Training Group) or 20 weeks post-randomization (Control Group) |
| Positive Effects Assessed With Adapted Items From the Oxford VR Side Effects Checklist | Positive effects will be assessed using three adapted items from the Oxford VR Side Effects Checklist (O-VRES). Items are rated on a 5-point Likert scale. Total scores range from 3 to 15, with higher scores indicating greater endorsement of positive effects. | 10 weeks post-randomization (Training Group) or 20 weeks post-randomization (Control Group) |
| Klinika za psihijatriju Sveti Ivan | Zagreb | 10000 | Croatia |
|
| University Medical Center of Johannes Gutenberg University Mainz | Mainz | Rhineland-Palatinate | 55131 | Germany |
|
| Hospital José Joaquim Fernandes | Beja | Beja District | 7801-849 | Portugal |
|
| Del Henares University Hospital | Coslada | Madrid | 28822 | Spain |
|
| Summa 112 | Madrid | Madrid | 28005 | Spain |
|
| Infanta Leonor University Hospital | Madrid | Madrid | 28031 | Spain |
|
| Infanta Sofía University Hospital | San Sebastián de los Reyes | Madrid | 28702 | Spain |
|
| Apr 13, 2026 |
| Prot_SAP_ICF_000.pdf |
| ID | Term |
|---|---|
| D000073397 | Occupational Stress |
| D000092862 | Psychological Well-Being |
| D000077062 | Burnout, Psychological |
| ID | Term |
|---|---|
| D009784 | Occupational Diseases |
| D013315 | Stress, Psychological |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D010549 | Personal Satisfaction |
Not provided
Not provided